SeaStar Medical Holding (ICU)
NASDAQ:ICU
Total Valuation
SeaStar Medical Holding has a market cap or net worth of $18.29M. The enterprise value is $1.32M.
Market Cap$18.29M
Enterprise Value$1.32M
Share Statistics
SeaStar Medical Holding has 3,993,719 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,993,719
Owned by Insiders3.38%
Owned by Institutions<0.01%
Financial Efficiency
SeaStar Medical Holding’s return on equity (ROE) is -1.17 and return on invested capital (ROIC) is -111.28%.
Return on Equity (ROE)-1.17
Return on Assets (ROA)-0.86
Return on Invested Capital (ROIC)-111.28%
Return on Capital Employed (ROCE)-1.17
Revenue Per Employee64.95K
Profits Per Employee-639.47K
Employee Count19
Asset Turnover0.09
Inventory Turnover0.80
Valuation Ratios
The current PE Ratio of SeaStar Medical Holding is ―. SeaStar Medical Holding’s PEG ratio is 0.04.
PE Ratio―
PS Ratio40.32
PB Ratio4.78
Price to Fair Value4.78
Price to FCF-3.66
Price to Operating Cash Flow-6.98
PEG Ratio0.04
Income Statement
In the last 12 months, SeaStar Medical Holding had revenue of 1.23M and earned -12.15M in profits. Earnings per share was -5.86.
Revenue1.23M
Gross Profit1.18M
Operating Income-12.18M
Pretax Income-12.15M
Net Income-12.15M
EBITDA-12.18M
Earnings Per Share (EPS)-5.86
Cash Flow
In the last 12 months, operating cash flow was -13.60M and capital expenditures 0.00, giving a free cash flow of -13.60M billion.
Operating Cash Flow-13.60M
Free Cash Flow-13.60M
Free Cash Flow per Share-3.41
Dividends & Yields
SeaStar Medical Holding pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.57
52-Week Price Change-65.82%
50-Day Moving Average2.63
200-Day Moving Average4.90
Relative Strength Index (RSI)80.84
Average Volume (3m)3.06M
Important Dates
SeaStar Medical Holding upcoming earnings date is May 19, 2026, After Close (Confirmed).
Last Earnings DateMar 25, 2026
Next Earnings DateMay 19, 2026
Ex-Dividend Date―
Financial Position
SeaStar Medical Holding as a current ratio of 3.63, with Debt / Equity ratio of 5.04%
Current Ratio3.63
Quick Ratio3.61
Debt to Market Cap0.01
Net Debt to EBITDA0.94
Interest Coverage Ratio-37.01
Taxes
In the past 12 months, SeaStar Medical Holding has paid 3.00K in taxes.
Income Tax3.00K
Effective Tax Rate>-0.01
Enterprise Valuation
SeaStar Medical Holding EV to EBITDA ratio is -3.15, with an EV/FCF ratio of -2.82.
EV to Sales31.04
EV to EBITDA-3.15
EV to Free Cash Flow-2.82
EV to Operating Cash Flow-2.82
Balance Sheet
SeaStar Medical Holding has $11.98M in cash and marketable securities with $525.00K in debt, giving a net cash position of $11.46M billion.
Cash & Marketable Securities$11.98M
Total Debt$525.00K
Net Cash$11.46M
Net Cash Per Share$2.87
Tangible Book Value Per Share$0.50
Margins
Gross margin is 95.71%, with operating margin of -986.63%, and net profit margin of -984.60%.
Gross Margin95.71%
Operating Margin-986.63%
Pretax Margin-984.36%
Net Profit Margin-984.60%
EBITDA Margin-986.63%
EBIT Margin-986.63%
Analyst Forecast
The average price target for SeaStar Medical Holding is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside160.87% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast1195.59%
EPS Growth Forecast87.66%